The global radioimmunoassay (RIA) market is experiencing steady growth, driven by its critical role in clinical diagnostics and research applications. Expanding at a CAGR of 3%, the global radioimmunoassays market is valued at US$ 420.15 million in 2023 and is projected to reach a valuation of US$ 564.65 million by the end of 2033. RIA is an in-vitro assay technique that utilizes...